Drugs News and Research

RSS

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

Multiple myeloma is the second most common blood cancer in the United States. Thirty to 50 percent of multiple myeloma patients have extra copies of the gene that encodes the enzyme ADAR1.

6 Dec 2017

Attack on asthma: Scrubbing homes of allergens may tame disease and its costs

After years of studying the causes of asthma, a pediatrician-turned-public health sleuth thinks there's a way to substantially reduce its impact.

6 Dec 2017

Intensive weight management program can help people with type 2 diabetes achieve remission

Type 2 diabetes can be reversed following an intensive weight management program, according a randomized trial in adults who have had the condition for up to 6 years, published in The Lancet.

6 Dec 2017

UT Southwestern researchers identify potential approach to suppress lethal parasitic infections

UT Southwestern Medical Center researchers have identified a chemical that suppresses the lethal form of a parasitic infection caused by roundworms that affects up to 100 million people and usually causes only mild symptoms.

5 Dec 2017

Patients with RBD sleep disorder have risk of developing Parkinson's disease in future

Researchers from Aarhus University have discovered that patients with the RBD sleep behavior disorder lack dopamine and have a form of inflammation of the brain. This means that they are at risk of developing Parkinson's disease or dementia when they grow older.

5 Dec 2017

Researchers identify way to prevent fat cells from growing larger

Researchers at Washington University School of Medicine in St. Louis have identified a way to prevent fat cells from growing larger, a process that leads to weight gain and obesity. By activating a pathway in fat cells in mice, the researchers found they could feed the animals a high-fat diet without making them obese.

5 Dec 2017

Immune-boosting drug combination may hold promise for treating ovarian cancer

Johns Hopkins Kimmel Cancer Center researchers demonstrated that mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden and significantly longer survival than those that received any of the drugs alone.

5 Dec 2017

BU researchers receive $2.7 million grant to find better ways of delivering anti-retrovirals

Rahm Gummuluru, PhD, associate professor of microbiology at Boston University School of Medicine, and Bjoern Reinhard, PhD, professor of chemistry at Boston University, have been awarded a Research Project Grant from the National Institutes of Allergy and Infectious Diseases/National Institute of Health.

5 Dec 2017

Researcher discovers enzyme pathway involved in ALS pathogenesis

It is estimated that between 14,000 and 15,000 Americans have amyotrophic lateral sclerosis (ALS), according to the National Institutes of Health. Symptoms of ALS, also known as Lou Gehrig's disease, may be subtle at first but develop into more obvious muscle weakness and paralysis.

5 Dec 2017

New small-molecule drug restores brain function, memory in mouse model of Alzheimer's disease

An international team of researchers has shown that a new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer's disease.

5 Dec 2017

Biological Applications of AFM

An interview with Samuel Lesko, European Applications Manager, Bruker Nano Surfaces conducted by April Cashin-Garbutt, MA (Cantab).

From Bruker Nano Surfaces and Metrology 5 Dec 2017

MILabs’ versatile Hybrid OI/CT system installed at Guangdong University of Technology

The Institute of Biomedical and Pharmaceutical Sciences at Guangdong University of Technology in Guangzhou – China, has successfully installed a VECTor5 Hybrid OI/CT system from MILabs.

5 Dec 2017

New biomarker test can accurately predict which chemical compounds induce DNA damage

A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.

5 Dec 2017

Clearance of cancer cell debris via pro-resolving mediators can prevent tumor recurrence

Cancer therapies are designed to kill tumor cells, but produce tumor cell debris in the process. In a study published in The Journal of Experimental Medicine, researchers from Brigham and Women's Hospital and colleagues show that leftover debris can stimulate inflammation and tumor growth, but that molecules called resolvins can block that unwanted inflammatory response.

5 Dec 2017

OICR announces innovative initiative to drive development of new cancer therapies

The Ontario Institute for Cancer Research today announced the Cancer Therapeutics Innovation Pipeline initiative and the first 10 projects selected in CTIP's inaugural round of funding.

4 Dec 2017

Parental attention can be protective factor to lower risk of drug abuse among adolescents

Parents who require children to follow rules and keep a constant eye on their activities, endeavoring to know where they are, who they are with and what they are doing, run less risk of facing problems when their children enter adolescence, such as abuse of alcohol and other drugs.

4 Dec 2017

Drugs News and Research

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

Attack on asthma: Scrubbing homes of allergens may tame disease and its costs

Intensive weight management program can help people with type 2 diabetes achieve remission

UT Southwestern researchers identify potential approach to suppress lethal parasitic infections

Patients with RBD sleep disorder have risk of developing Parkinson's disease in future

Researchers identify way to prevent fat cells from growing larger

Immune-boosting drug combination may hold promise for treating ovarian cancer

BU researchers receive $2.7 million grant to find better ways of delivering anti-retrovirals

Researcher discovers enzyme pathway involved in ALS pathogenesis

New small-molecule drug restores brain function, memory in mouse model of Alzheimer's disease

Biological Applications of AFM

MILabs’ versatile Hybrid OI/CT system installed at Guangdong University of Technology

New biomarker test can accurately predict which chemical compounds induce DNA damage

Clearance of cancer cell debris via pro-resolving mediators can prevent tumor recurrence

OICR announces innovative initiative to drive development of new cancer therapies

Parental attention can be protective factor to lower risk of drug abuse among adolescents

Study shows connection between common hypertension drug and skin cancer

Kent researchers establish first long-term cultivation system for diarrhea-causing parasite

Research could contribute to development of therapeutic drug and vaccine against malaria

Malvern Panalytical Announce Efforts Towards a Platform For Protein Aggregation Profiling

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News